World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Integra Lifesciences Holdings Corporation

    World Rank (Aug-2026)
    7,657
    Market Cap (Aug-2026)
    1.426 Billion USD
    World Rank (Jan-05-2024)
    4,140
    Market Cap (Jan-05-2024)
    3.237 Billion USD
    World Rank (Jul-30-2023)
    3,730
    Market Cap (Jul-30-2023)
    3.727 Billion USD
    World Rank (Dec-25-2022)
    2,884
    Market Cap (Dec-25-2022)
    4.701 Billion USD
    World Rank (Jan-07-2022)
    3,009
    Market Cap (Jan-07-2022)
    5.58 Billion USD
    Annual Revenue in USD
    1,635 Million USD
    Annual Operating Income in USD
    -493 Million USD
    Annual Net Income in USD
    -516 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Integra LifeSciences is Medical devices and medical instruments manufacturing company with headquarters is in New Jersey, USA.

    Integra LifeSciences offers innovative solutions in orthopedics, neurosurgery, and reconstructive and general surgery.

    For year ending December 2022, Annual Revenues was 1,557 Million USD and Net Income was 180 Million USD.

    Facts About Company

    For year ending December 2022, Annual Revenues was 1,557 Million USD and Net Income was 180 Million USD.

    As of December 2020, Integra LifeSciences had approximately 3,700 full-time and part-time employees and 700 subcontracted and outsourced partners.

    Company Website
    INTEGRA LIFESCIENCES HOLDINGS CORPORATION

  2. MoonLake Immunotherapeutics

    World Rank (Aug-2026)
    7,733
    Market Cap (Aug-2026)
    1.402 Billion USD
    World Rank (Jan-05-2024)
    3,968
    Market Cap (Jan-05-2024)
    3.404 Billion USD
    World Rank (Jul-30-2023)
    4,196
    Market Cap (Jul-30-2023)
    3.164 Billion USD
    World Rank (Dec-25-2022)
    14,035
    Market Cap (Dec-25-2022)
    0.390 Billion USD
    Headquarters Country
    Switzerland
    Company Profile
    MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.
    Company Website
    MOONLAKE IMMUNOTHERAPEUTICS

  3. Celltrion Pharm Inc.

    World Rank (Aug-2026)
    7,742
    Market Cap (Aug-2026)
    1.398 Billion USD
    World Rank (Jan-05-2024)
    3,791
    Market Cap (Jan-05-2024)
    3.621 Billion USD
    World Rank (Jul-30-2023)
    5,151
    Market Cap (Jul-30-2023)
    2.366 Billion USD
    World Rank (Dec-25-2022)
    5,609
    Market Cap (Dec-25-2022)
    1.902 Billion USD
    Headquarters Country
    South Korea
    Company Profile

    Biotechnology sector company with headquarters in South Korea.

    Company Website
    CELLTRION PHARM, INC.

  4. Imago Biosciences Inc.

    World Rank (Aug-2026)
    7,762
    World Rank (Jan-05-2024)
    7,762
    World Rank (Jul-30-2023)
    7,762
    Market Cap (Jul-30-2023)
    1.220 Billion USD
    World Rank (Dec-25-2022)
    7,472
    Market Cap (Dec-25-2022)
    1.216 Billion USD
    World Rank (Jan-07-2022)
    11,646
    Market Cap (Jan-07-2022)
    0.67 Billion USD
    Annual Operating Income in USD
    -43 Million USD
    Annual Net Income in USD
    -42 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    USA
    Company Profile
    Biotechnology sector company with headquarters is in USA.
    Company Website
    IMAGO BIOSCIENCES, INC.

  5. Replimune Group

    World Rank (Aug-2026)
    7,786
    Market Cap (Aug-2026)
    1.384 Billion USD
    World Rank (Jan-05-2024)
    12,365
    Market Cap (Jan-05-2024)
    0.520 Billion USD
    World Rank (Jul-30-2023)
    7,950
    Market Cap (Jul-30-2023)
    1.172 Billion USD
    World Rank (Dec-25-2022)
    7,081
    Market Cap (Dec-25-2022)
    1.332 Billion USD
    World Rank (Jan-07-2022)
    8,400
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Operating Income in USD
    -320 Million USD
    Annual Net Income in USD
    -314 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Replimune Group is an emerging class of Cancer Therapeutics company that exploits the ability of viruses to selectively replicate in and kill tumors while at the same time inducing a potent, patient specific, anti tumor immune response. The headquarters is in USA.

    Facts About Company

    Replimune Group Annual Net loss for year ending Mar-2023 was -174 million USD.

    Replimune Group Annual Net loss for year ending Mar-2022 was -118 million USD.

    As on 2023, Replimune Group has 284 employees.

    Company Website
    REPLIMUNE GROUP

  6. Cti Biopharma

    World Rank (Aug-2026)
    7,854
    World Rank (Jan-05-2024)
    7,854
    World Rank (Jul-30-2023)
    7,854
    Market Cap (Jul-30-2023)
    1.200 Billion USD
    World Rank (Dec-25-2022)
    10,235
    Market Cap (Dec-25-2022)
    0.714 Billion USD
    World Rank (Jan-07-2022)
    18,442
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    54 Million USD
    Annual Operating Income in USD
    -80 Million USD
    Annual Net Income in USD
    -93 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Website
    CTI BIOPHARMA

  7. Vor Biopharma Inc.

    World Rank (Aug-2026)
    7,864
    Market Cap (Aug-2026)
    1.363 Billion USD
    World Rank (Jan-05-2024)
    19,708
    Market Cap (Jan-05-2024)
    0.141 Billion USD
    World Rank (Jul-30-2023)
    18,336
    Market Cap (Jul-30-2023)
    0.189 Billion USD
    World Rank (Dec-25-2022)
    12,953
    Market Cap (Dec-25-2022)
    0.460 Billion USD
    World Rank (Jan-07-2022)
    14,870
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Annual Operating Income in USD
    -372 Million USD
    Annual Net Income in USD
    -696 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    VOR BIOPHARMA INC.

  8. Vcanbio Cell & Gene Engineering Ltd

    World Rank (Aug-2026)
    7,881
    Market Cap (Aug-2026)
    1.358 Billion USD
    World Rank (Jan-05-2024)
    7,444
    Market Cap (Jan-05-2024)
    1.282 Billion USD
    World Rank (Jul-30-2023)
    8,095
    Market Cap (Jul-30-2023)
    1.139 Billion USD
    World Rank (Dec-25-2022)
    7,720
    Market Cap (Dec-25-2022)
    1.148 Billion USD
    World Rank (Jan-07-2022)
    6,650
    Market Cap (Jan-07-2022)
    1.83 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    VCANBIO CELL & GENE ENGINEERING LTD

  9. Novavax

    World Rank (Aug-2026)
    7,980
    Market Cap (Aug-2026)
    1.328 Billion USD
    World Rank (Jan-05-2024)
    11,359
    Market Cap (Jan-05-2024)
    0.613 Billion USD
    World Rank (Jul-30-2023)
    10,617
    Market Cap (Jul-30-2023)
    0.708 Billion USD
    World Rank (Dec-25-2022)
    9,445
    Market Cap (Dec-25-2022)
    0.821 Billion USD
    World Rank (Jan-07-2022)
    1,955
    Market Cap (Jan-07-2022)
    9.58 Billion USD
    Annual Revenue in USD
    1,123 Million USD
    Annual Operating Income in USD
    453 Million USD
    Annual Net Income in USD
    440 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.

    Company Website
    NOVAVAX
    Wikipedia
    Wikipedia

  10. Monte Rosa Therapeutics Inc.

    World Rank (Aug-2026)
    8,001
    Market Cap (Aug-2026)
    1.322 Billion USD
    World Rank (Jan-05-2024)
    15,682
    Market Cap (Jan-05-2024)
    0.304 Billion USD
    World Rank (Jul-30-2023)
    14,960
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    14,146
    Market Cap (Dec-25-2022)
    0.384 Billion USD
    World Rank (Jan-07-2022)
    10,718
    Market Cap (Jan-07-2022)
    0.79 Billion USD
    Annual Revenue in USD
    124 Million USD
    Annual Operating Income in USD
    -54 Million USD
    Annual Net Income in USD
    -39 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Website
    MONTE ROSA THERAPEUTICS, INC.

Share